IL17A and psoriasis: The levels of the cytokine IL-17 are also elevated in psoriasis [36,37] and an anti-IL-17 medication (Ixekizumab; brand name Taltz) recently approved by the Food and Drug Administration has shown efficacy for the treatment of psoriasis [38].